A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

Clinical trial NCT07124117 · RECRUITING

Trial details

NCT number: NCT07124117
Sponsor: OBI Pharma, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-08-04
Primary completion: 2029-02-08
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.